79
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Nucleotide-Oligomerizing Domain-1 Activation Exaggerates Cigarette Smoke-Induced Chronic Obstructive Pulmonary-Like Disease in Mice

, , , &
Pages 2605-2615 | Published online: 16 Sep 2021

References

  • MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):258–266. doi:10.1513/pats.200504-045SR
  • Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
  • Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351. doi:10.1016/S0140-6736(11)60968-9
  • McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2.
  • Tuder RM, Petrache I. Pathogenesis of chronic obstructive pulmonary disease. J Clin Invest. 2012;122(8):2749–2755. doi:10.1172/JCI60324
  • MacNee W. Accelerated lung aging: a novel pathogenic mechanism of chronic obstructive pulmonary disease (COPD). Biochem Soc Trans. 2009;37(Pt 4):819–823. doi:10.1042/BST0370819
  • Price D, Yawn B, Brusselle G, Rossi A. Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD. Prim Care Respir J. 2013;22(1):92–100. doi:10.4104/pcrj.2012.00092
  • Rodriguez E, Ferrer J, Zock JP, et al. Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients. PLoS One. 2014;9(2):e88426. doi:10.1371/journal.pone.0088426
  • Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
  • Tashkin DP. Smoking cessation in chronic obstructive pulmonary disease. Semin Respir Crit Care Med. 2015;36(4):491–507. doi:10.1055/s-0035-1555610
  • Zuo L, He F, Sergakis GG, et al. Interrelated role of cigarette smoking, oxidative stress, and immune response in COPD and corresponding treatments. Am J Physiol Lung Cell Mol Physiol. 2014;307(3):L205–L218. doi:10.1152/ajplung.00330.2013
  • Liu Y, Pleasants RA, Croft JB, et al. Smoking duration, respiratory symptoms, and COPD in adults aged >/=45 years with a smoking history. Int J Chron Obstruct Pulmon Dis. 2015;10:1409–1416. doi:10.2147/COPD.S82259
  • Amatngalim GD, Broekman W, Daniel NM, et al. Cigarette smoke modulates repair and innate immunity following injury to airway epithelial cells. PLoS One. 2016;11(11):e0166255. doi:10.1371/journal.pone.0166255
  • Sethi S, Mahler DA, Marcus P, Owen CA, Yawn B, Rennard S. Inflammation in COPD: implications for management. Am J Med. 2012;125(12):1162–1170. doi:10.1016/j.amjmed.2012.06.024
  • Tamimi A, Serdarevic D, Hanania NA. The effects of cigarette smoke on airway inflammation in asthma and COPD: therapeutic implications. Respir Med. 2012;106(3):319–328. doi:10.1016/j.rmed.2011.11.003
  • Fernandez-Velasco M, Prieto P, Terron V, et al. NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis. PLoS One. 2012;7(9):e45260. doi:10.1371/journal.pone.0045260
  • Franchi L, Warner N, Viani K, Nunez G. Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev. 2009;227(1):106–128. doi:10.1111/j.1600-065X.2008.00734.x
  • Shigeoka AA, Kambo A, Mathison JC, et al. Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol. 2010;184(5):2297–2304. doi:10.4049/jimmunol.0903065
  • Cardenas I, Mulla MJ, Myrtolli K, et al. Nod1 activation by bacterial iE-DAP induces maternal-fetal inflammation and preterm labor. J Immunol. 2011;187(2):980–986. doi:10.4049/jimmunol.1100578
  • Tukhvatulin AI, Logunov DY, Gitlin II, et al. A in vitro and in vivo study of the ability of NOD1 ligands to activate the transcriptional factor NF-kB. Acta Naturae. 2011;3(1):77–84. doi:10.32607/20758251-2011-3-1-77-84
  • Yu JS, Jin J, Li YY. The physiological functions of IKK-selective substrate identification and their critical roles in diseases. STEMedicine. 2020;1(4):e49. doi:10.37175/stemedicine.v1i4.49
  • Yang H, Li N, Song LN, et al. Activation of NOD1 by DAP contributes to myocardial ischemia/reperfusion injury via multiple signaling pathways. Apoptosis. 2015;20(4):512–522. doi:10.1007/s10495-015-1089-1
  • Moreira LO, Zamboni DS. NOD1 and NOD2 signaling in infection and inflammation. Front Immunol. 2012;3:328. doi:10.3389/fimmu.2012.00328
  • Di Stefano A, Ricciardolo FLM, Caramori G, et al. Bronchial inflammation and bacterial load in stable COPD is associated with TLR4 overexpression. Eur Respir J. 2017;49(5):1602006. doi:10.1183/13993003.02006-2016
  • Kinose D, Ogawa E, Hirota T, et al. A NOD2 gene polymorphism is associated with the prevalence and severity of chronic obstructive pulmonary disease in a Japanese population. Respirology. 2012;17(1):164–171. doi:10.1111/j.1440-1843.2011.02069.x
  • Belhaj R, Kaabachi W, Khalfallah I, Hamdi B, Hamzaoui K, Hamzaoui A. Gene variants, mRNA and NOD1/2 protein levels in tunisian childhood asthma. Lung. 2019;197(3):377–385. doi:10.1007/s00408-019-00209-4
  • Liu Y, Huang ZZ, Min L, Li ZF, Chen K. The BRD4 inhibitor JQ1 protects against chronic obstructive pulmonary disease in mice by suppressing NF-kappaB activation. Histol Histopathol. 2021;36(1):101–112.
  • Liang X, Wang J, Guan R, et al. Limax extract ameliorates cigarette smoke-induced chronic obstructive pulmonary disease in mice. Int Immunopharmacol. 2018;54:210–220. doi:10.1016/j.intimp.2017.11.004
  • Nie YC, Wu H, Li PB, et al. Characteristic comparison of three rat models induced by cigarette smoke or combined with LPS: to establish a suitable model for study of airway mucus hypersecretion in chronic obstructive pulmonary disease. Pulm Pharmacol Ther. 2012;25(5):349–356. doi:10.1016/j.pupt.2012.06.004
  • Zhang WG, He L, Shi XM, et al. Regulation of transplanted mesenchymal stem cells by the lung progenitor niche in rats with chronic obstructive pulmonary disease. Respir Res. 2014;15:33. doi:10.1186/1465-9921-15-33
  • Tukhvatulin AI, Gitlin II, Shcheblyakov DV, et al. Combined stimulation of Toll-like receptor 5 and NOD1 strongly potentiates activity of NF-kappaB, resulting in enhanced innate immune reactions and resistance to Salmonella enterica serovar Typhimurium infection. Infect Immun. 2013;81(10):3855–3864. doi:10.1128/IAI.00525-13
  • Gebel S, Diehl S, Pype J, et al. The transcriptome of Nrf2-/- mice provides evidence for impaired cell cycle progression in the development of cigarette smoke-induced emphysematous changes. Toxicol Sci. 2010;115(1):238–252. doi:10.1093/toxsci/kfq039
  • Knudsen L, Weibel ER, Gundersen HJ, Weinstein FV, Ochs M. Assessment of air space size characteristics by intercept (chord) measurement: an accurate and efficient stereological approach. J Appl Physiol. 2010;108(2):412–421. doi:10.1152/japplphysiol.01100.2009
  • Van Hoecke L, Job ER, Saelens X, Roose K. Bronchoalveolar lavage of murine lungs to analyze inflammatory cell infiltration. J Vis Exp. 2017;123:e55398.
  • Wang G, Mohammadtursun N, Lv Y, Zhang H, Sun J, Dong J. Baicalin exerts anti-airway inflammation and anti-remodelling effects in severe stage rat model of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med. 2018;2018:7591348. doi:10.1155/2018/7591348
  • Zhou X, Moore BB. Lung section staining and microscopy. Bio Protoc. 2017;7(10).
  • Caruso R, Warner N, Inohara N, Nunez G. NOD1 and NOD2: signaling, host defense, and inflammatory disease. Immunity. 2014;41(6):898–908. doi:10.1016/j.immuni.2014.12.010
  • Kanneganti TD, Lamkanfi M, Nunez G. Intracellular NOD-like receptors in host defense and disease. Immunity. 2007;27(4):549–559. doi:10.1016/j.immuni.2007.10.002
  • Wietzerbin J, Das BC, Petit JF, Lederer E, Leyh-Bouille M, Ghuysen JM. Occurrence of D-alanyl-(D)-meso-diaminopimelic acid and meso-diaminopimelyl-meso-diaminopimelic acid interpeptide linkages in the peptidoglycan of Mycobacteria. Biochemistry. 1974;13(17):3471–3476. doi:10.1021/bi00714a008
  • Sorbara MT, Ellison LK, Ramjeet M, et al. The protein ATG16L1 suppresses inflammatory cytokines induced by the intracellular sensors Nod1 and Nod2 in an autophagy-independent manner. Immunity. 2013;39(5):858–873. doi:10.1016/j.immuni.2013.10.013
  • Grubman A, Kaparakis M, Viala J, et al. The innate immune molecule, NOD1, regulates direct killing of Helicobacter pylori by antimicrobial peptides. Cell Microbiol. 2010;12(5):626–639. doi:10.1111/j.1462-5822.2009.01421.x
  • Juarez E, Carranza C, Hernandez-Sanchez F, et al. Nucleotide-oligomerizing domain-1 (NOD1) receptor activation induces pro-inflammatory responses and autophagy in human alveolar macrophages. BMC Pulm Med. 2014;14:152. doi:10.1186/1471-2466-14-152
  • Hasegawa M, Fujimoto Y, Lucas PC, et al. A critical role of RICK/RIP2 polyubiquitination in Nod-induced NF-kappaB activation. EMBO J. 2008;27(2):373–383. doi:10.1038/sj.emboj.7601962
  • Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11(1):55–62. doi:10.1038/ni.1823
  • Roussel L, Rousseau S. IL-17 primes airway epithelial cells lacking functional cystic fibrosis transmembrane conductance regulator (CFTR) to increase NOD1 responses. Biochem Biophys Res Commun. 2010;391(1):505–509. doi:10.1016/j.bbrc.2009.11.088
  • Gao Y, Jiang W, Qian Y, et al. NOD1 agonist iE-DAP reverses effects of cigarette smoke extract on NOD1 signal pathway in human oral mucosal epithelial cells. Int J Clin Exp Med. 2015;8(8):12519–12528.